Home » Antiviral Pharma Chimerix Gets $81 Million Contract for Smallpox Countermeasure
Antiviral Pharma Chimerix Gets $81 Million Contract for Smallpox Countermeasure
Antiviral therapeutics company Chimerix has received a federal contract that could reach $81 million in value if the company successfully develops a medical countermeasure to a smallpox bioterrorism agent.
MedCity News
MedCity News
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May